User:Arthur Migliatti/Sandbox1
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
'''Thioredoxin'''(Trx) is a protein present in all organisms, from bacterias to complex beings as humans. This page will be focused on exploring the characteristics of '''Trx1''', a cytosolic form of Trx present in eukaryotes. Trx1 has an active site composed of 2 cysteines separated by 2 aminoacids (<scene name='91/911850/Trx_cys-active_site/2'>Cys32 - X - X - Cys35</scene>) which catalyses the reduction of other thiol-proteins and becomes oxidized. It is reduced back by '''[[Thioredoxin Reductase]]'''(TrxR), which, in the end, is reduced by '''NADPH'''. Together, the two proteins and NADPH form the system Trx<ref>Lu, J.; Holmgren, A. The Thioredoxin Antioxidant System. Free Radical Biology and Medicine 2014, 66, 75–87. https://doi.org/10.1016/j.freeradbiomed.2013.07.036.</ref>. As it is shown in this <scene name='91/911850/Conservation/1'>image</scene>, both Cys32 and Cys 35 were highly conserved during evolution(<font color='mediumvioletred'><b>dark pink</b></font>). One of the most important proteins that Trx reduces is '''[[Peroxiredoxin]]'''(Prx), which catalyses the reduction of Hidrogen Peroxide(H2O2) to water. Since high concentrations of H2O2 produces other potent oxidizing molecules, such as hydroxyl radical, Prx's action, and so Trx's also, are fundamental for the cell to have a redox homeostasis and to have low amount of damage. | '''Thioredoxin'''(Trx) is a protein present in all organisms, from bacterias to complex beings as humans. This page will be focused on exploring the characteristics of '''Trx1''', a cytosolic form of Trx present in eukaryotes. Trx1 has an active site composed of 2 cysteines separated by 2 aminoacids (<scene name='91/911850/Trx_cys-active_site/2'>Cys32 - X - X - Cys35</scene>) which catalyses the reduction of other thiol-proteins and becomes oxidized. It is reduced back by '''[[Thioredoxin Reductase]]'''(TrxR), which, in the end, is reduced by '''NADPH'''. Together, the two proteins and NADPH form the system Trx<ref>Lu, J.; Holmgren, A. The Thioredoxin Antioxidant System. Free Radical Biology and Medicine 2014, 66, 75–87. https://doi.org/10.1016/j.freeradbiomed.2013.07.036.</ref>. As it is shown in this <scene name='91/911850/Conservation/1'>image</scene>, both Cys32 and Cys 35 were highly conserved during evolution(<font color='mediumvioletred'><b>dark pink</b></font>). One of the most important proteins that Trx reduces is '''[[Peroxiredoxin]]'''(Prx), which catalyses the reduction of Hidrogen Peroxide(H2O2) to water. Since high concentrations of H2O2 produces other potent oxidizing molecules, such as hydroxyl radical, Prx's action, and so Trx's also, are fundamental for the cell to have a redox homeostasis and to have low amount of damage. | ||
| - | Trx1 is a monomeric protein and weights around 12kDa. It is formed by one five-stranded beta sheets involved by 4 alpha helix, shown <scene name='91/911850/Secondary_structure/1'>here</scene>. | + | Trx1 is a monomeric protein and weights around 12kDa. It is formed by one five-stranded beta sheets involved by 4 alpha helix, shown <scene name='91/911850/Secondary_structure/1'>here</scene>. The active site is located on a lump between betra strand 2, where Cys 35 is located, and alpha helix 2, where Cys32 is located. By being in the end of an alpha helix, Cys32 has a lower pKa, making it possible to reduce dissulfide bonds.<ref>Holmgren, A. Thioredoxin Structure and Mechanism: Conformational Changes on Oxidation of the Active-Site Sulfhydryls to a Disulfide. Structure 1995, 3 (3), 239–243. https://doi.org/10.1016/S0969-2126(01)00153-8. |
| + | </ref> | ||
Trx and TrxR were first discovered in 1964 in a study realized in bacteria, and were described as necessary proteins to reduce '''[[Ribonucleotide Reductase]]'''(RNR), a protein that produces deoxyribonucleotides from ribonucleotides<ref>Laurent, T. C.; Moore, E. C.; Reichard, P. ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. J Biol Chem 1964, 239, 3436–3444.</ref>. | Trx and TrxR were first discovered in 1964 in a study realized in bacteria, and were described as necessary proteins to reduce '''[[Ribonucleotide Reductase]]'''(RNR), a protein that produces deoxyribonucleotides from ribonucleotides<ref>Laurent, T. C.; Moore, E. C.; Reichard, P. ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. J Biol Chem 1964, 239, 3436–3444.</ref>. | ||
Revision as of 00:17, 19 June 2022
Introduction
This is a default text for your page Arthur Migliatti/Sandbox1. Click above on edit this page to modify. Be careful with the < and > signs. You may include any references to papers as in: the use of JSmol in Proteopedia [1] or to the article describing Jmol [2] to the rescue.
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Lu, J.; Holmgren, A. The Thioredoxin Antioxidant System. Free Radical Biology and Medicine 2014, 66, 75–87. https://doi.org/10.1016/j.freeradbiomed.2013.07.036.
- ↑ Holmgren, A. Thioredoxin Structure and Mechanism: Conformational Changes on Oxidation of the Active-Site Sulfhydryls to a Disulfide. Structure 1995, 3 (3), 239–243. https://doi.org/10.1016/S0969-2126(01)00153-8.
- ↑ Laurent, T. C.; Moore, E. C.; Reichard, P. ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. J Biol Chem 1964, 239, 3436–3444.
- ↑ Tao, L.; Gao, E.; Bryan, N. S.; Qu, Y.; Liu, H.-R.; Hu, A.; Christopher, T. A.; Lopez, B. L.; Yodoi, J.; Koch, W. J.; Feelisch, M.; Ma, X. L. Cardioprotective Effects of Thioredoxin in Myocardial Ischemia and the Reperfusion Role of S-Nitrosation. Proc Natl Acad Sci U S A 2004, 101 (31), 11471–11476. https://doi.org/10.1073/pnas.0402941101.
- ↑ Tao, L.; Gao, E.; Bryan, N. S.; Qu, Y.; Liu, H.-R.; Hu, A.; Christopher, T. A.; Lopez, B. L.; Yodoi, J.; Koch, W. J.; Feelisch, M.; Ma, X. L. Cardioprotective Effects of Thioredoxin in Myocardial Ischemia and the Reperfusion Role of S-Nitrosation. Proc Natl Acad Sci U S A 2004, 101 (31), 11471–11476. https://doi.org/10.1073/pnas.0402941101.
